Duride

Duride is a pharmaceutical brand and entity primarily associated with the production and distribution of cardiovascular medications, specifically Isosorbide Mononitrate. The company focuses on providing treatments for chronic stable angina pectoris and managing symptoms of congestive heart failure. Its products are designed to improve blood flow by dilating blood vessels, thereby reducing the workload on the heart. Duride operates within the broader healthcare sector, ensuring the availability of essential cardiac therapies in various global markets. The company's business model centers on the commercialization of established therapeutic agents to address prevalent cardiovascular conditions.